medigraphic.com
ISSN 1561-3119 (Electronic)

2021, Number 3

<< Back Next >>

Rev Cubana Pediatr 2021; 93 (3)

Characterization of children diagnosed with COVID-19 in a province in the northern sierra of Peru

Oblitas GA, Herrera OJU, Hernández WR, Asenjo AJA, Sánchez DA

Language: Spanish
References: 49
Page: 1-18
PDF size: 536.07 Kb.


ABSTRACT

Introduction: Children population has low morbidity and mortality by COVID-19; however, children infected with SARS-CoV-2 are on the rise and may need to be characterized according to their various presentation variables.
Objective: Examine the social, clinical characteristics, epidemiological conditions and clinical picture of children diagnosed with COVID-19.
Methods: Retrospective descriptive study, with a sample of 88 children under 12 years old. The database of the hospital´s epidemiology office authorized for the registration of confirmed cases of COVID-19 in Chota province, Peru, was reviewed. Authorization was obtained from the institution's management to use the data exclusively for research purposes. The analysis period was from April 14, 2020 (zero case in the province) to January 28, 2021.
Results: In the sample 51.1% were women, the average age was 5.6 years; 10.2% were hospitalized, 83% were put in isolation, and 98.9% had a satisfactory recovery. The main manifestations in children were: cough, 26.1%; fever, 23.9% and headache, 19.3%. Epidemiological conditions detected were: 1.4% traveled in the last two weeks; 47.7% had intradomyciliary contagion, and 67% were asymptomatic. No children were reported deceased, intubated, ventilated or with pneumonia.
Conclusions: Children are just as susceptible to COVID-19 as other people; they have less severe clinical pictures that occur mainly with cough, fever, headache and general discomfort; they show a more favorable evolution and high prevalence of asymptomatic and intradomyciliary contagions.


REFERENCES

  1. Cohen J. Wuhan seafood market may not be source of novel virus spreading. EE. UU.: American Association for the Advancement of Science; 2021 [acceso 10/02/2021]. Disponible en: https://www.sciencemag.org/news/2020/01/wuhan-seafood-market-may-not-be-source-novel-virus-spreading-globally#[15/04/2020 23:07:10]

  2. Organización Mundial de la Salud. COVID-19: cronología de la actuación de la OMS. Ginebra: OMS; 2020 [acceso 10/02/2021]. Disponible en: https:// www.who.int/es/news-room/detail/08-04-2020-who-timeline--- covid-19

  3. Callaway E, Cyranoski D. What scientists want to know about the coronavirus outbreak. Nature. 2020 [acceso 09/02/2021];577:605-7. doi: https://doi.org/10.1038/d41586-020-00166-6

  4. Organización Mundial de la Salud. Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020. Ginebra: OMS; 2020 [acceso 12/02/2021]. Disponible en: https://www.who.int/es/dg/speeches/detail/ who-director-general-s-opening-remarks-at-the-media-briefingon-covid-19---11-march-2020

  5. Organización Mundial de la Salud. Cepa variante del SARS-CoV-2 – Reino Unido. Brotes epidémicos. Ginebra: OMS; 2021 [acceso 10/02/2021]. Disponible en: https://www.who.int/csr/don/21-december-2020-sars-cov2-variant-united-kingdom/es/

  6. Organización Panamericana de la Salud. COVID-19: las variantes de Sudáfrica, Inglaterra y Brasil amenazan América Latina. Washington: OPS; 2021 [acceso 11/02/2021]. Disponible en: https://news.un.org/es/story/2021/01/1487282

  7. Ministerio de Salud del Perú. Sala Situacional COVID-19 Perú. Lima: MINSA; 2021 [acceso 10/02/2021]. Disponible en: https://covid19.minsa.gob.pe/sala_situacional.asp

  8. Johns Hopkins University and Medicine. COVID19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. Baltimore, Maryland: University Johns Hopkins; 2021 [access 10/02/2021]. Disponible en: https://coronavirus.jhu.edu/map.html

  9. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from Chinese Center for Disease Control and Prevention. JAMA. 2020 [acceso 10/02/2021];323(13):1239-1242. doi: https://doi.org/10.1001/jama.2020.2648.

  10. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological featuresof 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020 [acceso 11/02/2021];20:689-696. Disponible en: https://www.thelancet.com/action/showPdf?pii=S1473-3099%2820%2930198-5

  11. Korean Center for Disease and Control and Prevention. Press Releases. Korea: Representación CDC; 2020 [access 14/02/2021]. Disponible en: https://www. cdc.go.kr/board/board.es?mid=a30402000000&bid=0030

  12. Hasan A, Mehmood N, Fergie J. Coronavirus disease (COVID-19) and pediatric patients: a review of epidemiology, symptomatology, laboratory and imaging results to guide the development of a management algorithm. Cureus. 2020 [acceso 20/04/2020];12(3):e7485. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123290/

  13. NYC Health. Italy: coronavirus cases by age 2020 Statista. Italia: NYC; 2020 [acceso 09/02/2021]. Disponible en: .https://www.statista.com/statistics/1103023/coronavirus-cases-distribution-by-age-groupitaly/

  14. NYC Health. Spain: coronavirus hospital case distribution by age 2020 Statista. España: NYC; 2020 [access 09/02/2021]. Disponible en: https://www.statista.com/statistics/1106425/c ovid-19-mortality-rate-by-age-group-in-spainmarch/

  15. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children. United States, February 12-April 2, 2020. MMWR. 2020 [acceso 11/02/2021];69(14):422-6. Disponible en: https://www.cdc.gov/mmwr/volumes/69/wr/mm6914e4.htm

  16. Muñoz-Hernández O, Solórzano-Santos F. COVID-19 pandemic: a different behavior in children. Bol Med Hosp Infant Mex. 2020 [12/02/2021];77(5):219-20. Disponible en: https://www.bmhim.com/frame_esp.php?id=171

  17. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-1095. doi: https://doi.org/10.1111/apa.15270

  18. Lu X, Zhang L, Li YY, Liu D, Shen K, Xu S, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663-5. doi: https://doi.org/10.1056/ NEJMc2005073.

  19. Singh T, Heston SM, Langel SN, Blasi M, Hurst JH, Fouda GG, et al. Lessons From COVID-19 in Children: Key Hypotheses to Guide Preventative and Therapeutic Strategies. CID. 2020;71(8):2006-13. doi: https://doi.org/10.1093/cid/ciaa547

  20. Organización Panamericana de la Salud. El COVID-19 infecta cada vez más a los niños y jóvenes de América Latina. Washington: OPS; 2020 [acceso 12/02/2021]. Disponible en: https://news.un.org/es/story/2020/10/1482002

  21. Instituto Nacional de Salud. Ministra Hinostroza pidió tener confianza en el Sistema de Salud tras confirmarse primer caso de coronavirus en Perú. Lima: INS; 2020 [acceso 14/02/2021]. Disponible en: http://web. ins.gob.pe/es/prensa/noticia/ministra-hinostroza-pidio-tenerconfianza-en-el-sistema-de-salud-tras-confirmarse

  22. Llaque P, Prudencio R, Echevarría S, Ccorahua M, Ugas C. Características clínicas y epidemiológicas de niños con covid-19 en un Hospital Pediátrico del Perú. Rev Perú Med Exp Salud Pública. 2020;37(4):689-693. doi: https://doi.org/10.17843/rpmesp.2020.374.6198

  23. Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults. Pediatric Pulmonol. 2020;55:1169-74. doi: https://doi.org/10.1002/ppul.24718

  24. Cai J, Xu J, Lin D, Xu L, Qu Z, Zhang Y, et al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. CDI. 2020;71(6):1547-1551. doi: https://doi.org/10.1093/cid/ciaa198

  25. Lee P, Hu Y, Chen P, Huang Y, Hsueh P. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020;53:371-2. doi: https://doi.org/10.1016/j.jmii.2020.02.011

  26. Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, et al. The different clinical characteristics of corona virus disease cases between children and their families in China–the character of children with COVID-19. Emerg Microbes Infect. 2020;9(1):707-13 doi: https://doi.org/10.1080/22221751.2020.1744483

  27. Zheng F, Liao C, Fan Q-h, Chen H-b, Zhao X-g, Xie Z-g, et al. Clinical characteristics of children with coronavirus disease 2019 in Hubei, China. Current Med Sc. 2020;40(2):275-80. doi: https://doi.org/10.1007/s11596-020-2172-6

  28. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6):1-12. doi: https://doi.org/10.1542/peds.2020-0702

  29. Wang D, Ju X, Xie F, Lu Y, Li F, Huang H, et al. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China. Chin J Pediatr. 2020;58(4):269-74. doi: https://doi.org/10.3760/cma.j.cn112140-20200225-00138

  30. Sun D, Li H, Lu X-X, Xiao H, Ren J, Zhang F-R, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World J Pediatrics. 2020;16:251-9. doi: https://doi.org/10.1007/s12519-020-00354-4

  31. Hong H, Wang Y, Chung H-T, Chen C-J. Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatr Neonatol. 2020;61(e2):131-2. doi: https://doi.org/10.1016/j.pedneo.2020.03.001

  32. Acosta J, Péres M, Rodríguez M, Morales A. COVID-19 en pediatría: aspectos clínicos, epidemiológicos, inmunopatogenia, diágnóstico y tratamiento. Rev Cubana Pediatr. 2020 [acceso 12/02/2021];92(e1152):1-22. Disponible en: http://www.revpediatria.sld.cu/index.php/ped/article/view/1152/547

  33. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-8. doi: https://doi.org/10.1016/S0140-6736(20)31103-x

  34. Ministerio de Salud. Ficha de Investigación Clínica y Epidemiológica COVID-19. Lima: MINSA; 2020 [acceso 17/04/2021]. Disponible en: https://www.sanbartolome.gob.pe/documentos/epidemiologia/2020/FIcha%20COVID-19.pdf

  35. Ministerio de Salud. Modelo de cuidado integral por curso de vida para la persona, familia y comunidad (MCI). Lima: MINSA; 2020 [acceso 16/04/2021]. Disponible en: https://www.gob.pe/institucion/minsa/normas-legales/414755-030-2020-minsa

  36. Instituto Nacional de Salud. informa sobre la entrega de resultados de pruebas moleculares para el diagnóstico de SARS-CoV-2. Lima: INS; 2020 [acceso 16/04/2021]. Disponible en: https://web.ins.gob.pe/es/prensa/noticia/comunicado-ins-informa-sobre-la-entrega-de-resultados-de-pruebas-moleculares-para-el#:~:text=Adem%C3%A1s%2C%20desde%20que%20llega%20la,d%C3%ADas%20en%20el%20%C3%BAltimo%20mes.

  37. Ministerio de Salud. Prevención, diagnóstico y tratamiento de personas afectadas por COVID-19 en el Perú. Lima: MINSA, Centro Nacional de Epidemiología (CDC); 2020 [acceso 16/04/2021]. Disponible en: https://cdn.www.gob.pe/uploads/document/file/582550/ANEXO_-_RM_193-2020-MINSA.PDF

  38. She J, Liu L, Liu W. COVID-19 epidemic: Disease characteristics in children. J Med Virol. 2020;92(7):747-54. doi: https://doi.org/10.1002/jmv.25807

  39. Morilla L, Morel Z, Pavlicich V. Características clínicas de los pacientes pediátricos con COVID-19 en un departamento de emergencia. Pediatr. (Asunción). 2020;47(3):124-31. doi: https://doi.org/10.31698/ped.47032020002

  40. García-Salido A. Three Hypotheses About Children COVID19. Pediatr Infect Dis J. 2020;39(7): e157. doi: https://doi.org/10.1097/INF.0000000000002701

  41. Gonçalves RB, Munhoz MA, Gomes F, Aparecida M. Caracterização da COVID-19 em crianças hospitalizadas. Rev Soc Bras Enferm Ped. 2020;20:36-48. doi: http://dx.doi.org/10.31508/1676-3793202000000125

  42. Posfay-Barbe KM, Wagner N, Gauthey M, Moussaoui D, Loevy N, Diana A, et al. COVID-19 in Children and the Dynamics of Infection in Families. Pediatrics. 2020;144(2): e20201576. doi: https://doi.org/10.1542/peds.2020-1576

  43. Fang F, LuoXP. Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives. Chin J Pediatr. 2020 [acceso 10/02/2021];58(2):81-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32023678/

  44. Yonker LM, Neilan AM, Bartsch Y, Patel AB, Regan J, Arya P, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses. J Pediatr. 2020;227:45-52(52e5). doi: https://doi.org/10.1016/j.jpeds.2020.08.037

  45. Paret M, Lighter J, Pellett Madan R, Raabe VN, Shust GF, Ratner AJ. SARS-CoV-2 infection (COVID19) in febrile infants without respiratory distress. CDI. 2020;71(16):2243-5. doi: https://doi.org/10.1016/j.jpeds.2020.08.037

  46. Parri N, Lenge M, Buonsenso D. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020;383:187-190. doi: https://doi.org/10.1056/NEJMc2008646

  47. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843-51. doi: https://doi.org/10.1111/apt.15731

  48. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427. doi: https://doi.org/10.1016/j.clim.2020.108427

  49. Ministerio de Salud. Directiva sanitaria para la vigilancia epidemiológica de la enfermedad por coronavirus (COVID-19) en el Perú. Lima: MINSA; 2021 [acceso 18/04/2021]. Disponible en: https://www.dge.gob.pe/portalnuevo/wp-content/uploads/2021/01/Directiva-de-vigilancia-de-COVID-19.pdf




2020     |     www.medigraphic.com